Overexpression of mutated Cu,Zn-SOD in neuroblastoma cells results in cytoskeletal change
Overexpression of mutated Cu,Zn-SOD in neuroblastoma cells results in cytoskeletal change
复制标题
DOI:
10.1152/ajpcell.00014.2004
复制
发表时间:
2005-02-01
影响因子:
5.5
通讯作者:
Taniguchi, N
中科院分区:
文献类型:
--
作者:
Takamiya, R;Takahashi, M;Taniguchi, N
Amyotrophic lateral sclerosis (ALS) involves the progressive degeneration of motor neurons in the spinal cord and the motor cortex. It has been shown that 15-20% of patients with familial ALS (FALS) have defects in the Sod1 gene, which encodes Cu, Zn-superoxide dismutase ( SOD). To elucidate the pathological role of mutated Cu, Zn-SOD, we examined the issue of whether mutated Cu, Zn-SOD affects the cell cycle. Mouse neuroblastoma Neuro-2a cells were transfected with human wild-type or mutated (G37R, G93A) Cu, Zn-SOD. Mutated, Cu, Zn-SOD-transfected cells exhibited marked retardation in cell growth and G(2)/M arrest. They also displayed lower reactivity to phalloidin, indicating that the cytoskeleton was disrupted. Immunoprecipitation, two-dimensional gel electrophoresis, and Western blot analysis indicated that mutated Cu,Zn-SOD associates with actin. Similar results were obtained by in vitro incubation experiments with purified actin and mutated Cu,Zn-SOD (G93A). These results suggest that mutated Cu,Zn-SOD in FALS causes cytoskeletal changes by associating with actin, which subsequently causes G(2)/M arrest and growth retardation.